Physician
Radiology
Dr. David E. Kuhl, MD
|
|
Give Review
David Kuhl is an expert in the field of Radiology. He went to Perelman School of Medicine at the University of Pennsylvania. He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Dr. David E. Kuhl is a published doctor as well. He has 101 publications published. The latest was: Cerebellar metabolic reduction in Alzheimer's disease and data normalization.
Publications
- Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
- Imaging butyrylcholinesterase activity in Alzheimer's disease.
- In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
- Neurochemical imaging of dementias.
- Tomographic mapping of human cerebral metabolism visual stimulation and deprivation.
- Electrocardiographic gating in positron emission computed tomography.
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings ...
- Assessment of regional myocardial ischemia by positron-emission computed tomography.
- Brain imaging of glucose utilization in convulsive disorders.
- Regional brain metabolism during seizures in humans.
- Positron computed tomography.
- Positron emission computed tomography in the diagnosis of dementia.
- Patterns of human local cerebral glucose metabolism during epileptic seizures.
- Dementia: clinical application of positron emission tomography.
- Emission computed tomography in the study of human epilepsy.
- Local cerebral metabolism during partial seizures.
- Cerebral metabolic relationships for selected brain regions in healthy adults.
- Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
- Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3.
- Scan detection of bone marrow infarcts in sickle cell disorders.
- Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms.
- Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphatase.
- Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism.
- Transverse-section radionuclide scanning in cisternography.
- Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distri...
- ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals.
- Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography.
- Perforated tape recorder for digital scan data store with grey shade and numeric readout.
- Control of oxidative degradation in 99mTc-labeled ferrous hydroxide: a simplified method.
- Comparison of rectilinear vertex and transverse section views in brain scanning.
- Optimizing the window of an Anger camera for 99m Tc.
- Failure to improve observer performance with scan smoothing.
- Quantitative section scanning using orthogonal tangent correction.
- Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography.
- Remote, semiautomated production of F-18-labeled 2-deoxy-2-fluoro-D-glucose.
- An investigation of a double-tracer technique for positron computerized tomography.
- A boundary method for attenuation correction in positron computed tomography.
- Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates.
- The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma.
- Correlations of glucose metabolism and structural damage to language function in aphasia.
- Brain glucose metabolism and memory functions: age decrease in factor scores.
- Cerebral glucose metabolism as a function of age in man: influence of the rate constants in the fluorodeoxyglucose method.
- Tomographic mapping of human cerebral metabolism: normal unstimulated state.
- Tomographic mapping of human cerebral metabolism: auditory stimulation.
- Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
- Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol.
- Imaging local brain function with emission computed tomography.
- Comparison of metabolic rates, language, and memory in subcortical aphasias.
- Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia.
- Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.
- Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
- PET and P300 relationships in early Alzheimer's disease.
- Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
- Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
- Scatter and attenuation correction for brain SPECT using attenuation distributions inferred from a head atlas.
- Tomographic mapping of human cerebral metabolism: sensory deprivation.
- The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
- Posterior cingulate cortex in Alzheimer''s disease.
- Local cerebral metabolic rates of glucose in movement and language disorders from positron tomography.
- 99mTc-hexamethylpropyleneamine oxime single photon emission CT in poststroke depression.
- Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose.
- Determinations of cerebral glucose utilization in dementia using positron emission tomography.
- Noninvasive determination of local cerebral metabolic rate of glucose in man.
- Brain glucose metabolism in Parkinson's disease.
- Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin.
- Effect of ischemia on quantification of local cerebral glucose metabolic rate in man.
- Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
- Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy.
- Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset.
- Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3.
- Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes.
- Correlation of criteria used for localizing epileptic foci in patients considered for surgical therapy of epilepsy.
- FDG positron emission computed tomography in a study of aphasia.
- The effect of normal aging on patterns of local cerebral glucose utilization.
- Comparative localization of epileptic foci in partial epilepsy by PCT and EEG.
- Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
- Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease.
- Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
- Clinical characterization of Alzheimer's disease: reliability of 'age at onset' and a new descriptor, 'age at shift'.
- Metabolic fate of [13N]ammonia in human and canine blood.
- Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics.
- Crossed cerebellar diaschisis: occurrence and resolution demonstrated with PET during carotid temporary balloon occlusion.
- Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography.
- SPECT imaging of moyamoya disease using 99mTc-HM-PAO. Comparison with computed tomography findings.
- Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain.
- [Integrated and automated data analysis for neuronal activation studies using positron emission tomography: methodology and applications].
- Absent splenic uptake of indium-111-oxine-labeled autologous leukocytes in functional asplenia.
- Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission ...
- Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
- Stereotaxic summation analysis of human cerebral benzodiazepine binding maps.
- The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
- Cerebellar metabolic reduction in Alzheimer's disease and data normalization.
- Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil.
- In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.
- [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.
- In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).
- [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.
- Dual-[11C]tracer single-acquisition positron emission tomography studies.
- Local cerebral metabolic rate for glucose during petit mal absences.
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.
Schools
Perelman School of Medicine University of Pennsylvania
Hospital Of The University Of Pennsylvania
Doctors Specialties
- Nuclear Medicine
- Radiation Oncology
- Radiology
Accepted Insurances
- Choice Plus POS II
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Shruti Jolly, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet E. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine E. Maturen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reshma Jagsi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Schmidlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon K. Zubieta, MD |
|
|
Dr. Kasey L. Morden, MD |
|
|
Dr. Iris Gluck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony N. Khuu, MD |
|
|
Dr. Ryan A. Dvorak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peggy S. Wu, MD |
|
|
Dr. Stuart E. Samuels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina H. Chapman, MD |
|
|
Ka K. Wong, MB BS |